Erratum: Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis
Frontiers Production Office
doaj +1 more source
Ceftazidime-avibactam in elastomeric pump for vascular graft infection: a case report. [PDF]
Berruti M +9 more
europepmc +1 more source
Yun Han,1,* Jianping Zhu,1,* Jieqiong Liu,2 Ying Zheng,2 Gang Liang,1 Yi Yang,1 Lingyan Yu,3 Zhenwei Yu,1 Gang Han1 1Research Center for Clinical Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, College of Pharmaceutical Sciences ...
Han Y +8 more
doaj
Avibactam-based combinations for the treatment of multidrug resistant Gram-negative bacilli infections. [PDF]
Tiseo G +4 more
europepmc +1 more source
Aztreonam-Avibactam Successfully Treated Severe <i>Stenotrophomonas maltophilia</i> Infection After Allogeneic Transplantation: A Case Report and Literature Reviews. [PDF]
Wang H +5 more
europepmc +1 more source
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc +1 more source
<i>In vitro</i> potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India. [PDF]
Bakthavatchalam YD +13 more
europepmc +1 more source
<i>In vitro</i> activities of aztreonam/nacubactam and cefepime/nacubactam against a global collection of molecularly characterized Enterobacterales isolates carrying carbapenemases: a global antimicrobial resistance surveillance study from 2021 to 2023. [PDF]
Estabrook M +3 more
europepmc +1 more source
Emergence of carbapenemase KPC-14 in an <i>Escherichia coli</i> isolate: a case report. [PDF]
Fontán García-Rodrigo L +4 more
europepmc +1 more source
Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]
Yaşar Duman M +4 more
europepmc +1 more source

